NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹43 Cr | ₹32 Cr | ₹20 Cr | ₹35 Cr | ₹14 Cr |
What is the latest Cash Flow from Operating Activities ratio of NGL FINECHEM ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹43 Cr |
| Mar2025 | ₹32 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹35 Cr |
| Mar2022 | ₹14 Cr |
How is Cash Flow from Operating Activities of NGL FINECHEM Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹43 Cr | 33.90 | |
| Mar2025 | ₹32 Cr | 58.07 | |
| Mar2024 | ₹20 Cr | -42.00 | |
| Mar2023 | ₹35 Cr | 155.23 | |
| Mar2022 | ₹14 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,938.4 Cr | 7.5% | 7.6% | 121.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,861.0 Cr | -2% | -6.1% | 12.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,319.0 Cr | 3.2% | 5.3% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,153.0 Cr | -1.9% | -2.9% | 32.7% | Stock Analytics | |
| CIPLA | ₹107,406.0 Cr | -1.5% | -4% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,362.0 Cr | -2.7% | 4.2% | -1.2% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 7.5% |
7.6% |
121.7% |
| SENSEX | 0.2% |
-4.6% |
-9.6% |
You may also like the below Video Courses